Evidence 1
Activity
Activity
IC50
IC50 = 20.1 µg/mL
Anticancer
20.1 µg/mL
Target
Lung Cancer
A-549
Lung
Assay & Model
MTT assay
48-h
Source & Reference
dbAMP 3.0
CancerPPD 2.0
dbACP
SATPdb
CancerPPD2
2020
Other
| Source Activity Label | Source Definition |
|---|---|
| Anticancer |
CancerPPD 2.0
manually curated experimentally verified anticancer peptide/protein annotation.
dbAMP 3.0
classified as Anticancer under the disease-associated peptide function classes.
|